Therapeutic impact of colon capsule endoscopy with PillCam™ COLON 2 after incomplete standard colonoscopya Spanish multicenter study
- Óscar Nogales Rincón 1
- J. García Lledó 1
- Marisol Luján-Sanchis 2
- D. Nicolás Pérez 3
- José Francisco Juanmartiñena Fernández 4
- Begoña González Suárez 5
- Francisco L. Sánchez Ceballos 6
- Ignacio Couto Wörner 7
- José Olmedo Camacho 8
- María Cristina Garfía Castillo 9
- Cristina Carretero Ribón 10
- Ignacio Fernández Urién 4
- Sarbelio Rodríguez Muloz 9
- Matilde Asteinza Daganzo 6
- Mª del Pilar Olivencia Palomar 8
- Ángeles Masedo González 9
- Miguel Ángel Muñoz Navas 11
- Beatriz Merino Rodríguez 1
- Cecilia González Asanza 1
-
1
Hospital General Universitario Gregorio Marañón
info
-
2
Hospital General Universitario de Valencia
info
-
3
Hospital Universitario de Canarias
info
- 4 Hospital de Navarra. Pamplona, Spain
-
5
Hospital Clinic Barcelona
info
-
6
Hospital Clínico San Carlos de Madrid
info
-
7
Complexo Hospitalario Universitario da Coruña
info
-
8
Hospital General de Ciudad Real
info
-
9
Hospital Universitario 12 de Octubre
info
-
10
Clínica Universitaria de Navarra
info
-
11
Universidad de Navarra
info
ISSN: 2340-416
Year of publication: 2017
Volume: 109
Issue: 5
Pages: 322-327
Type: Article
More publications in: Revista Española de Enfermedades Digestivas
Metrics
Cited by
JCR (Journal Impact Factor)
- Year 2017
- Journal Impact Factor: 1.632
- Journal Impact Factor without self cites: 1.247
- Article influence score: 0.335
- Best Quartile: Q4
- Area: GASTROENTEROLOGY & HEPATOLOGY Quartile: Q4 Rank in area: 66/80 (Ranking edition: SCIE)
SCImago Journal Rank
- Year 2017
- SJR Journal Impact: 0.417
- Best Quartile: Q3
- Area: Gastroenterology Quartile: Q3 Rank in area: 83/159
- Area: Medicine (miscellaneous) Quartile: Q3 Rank in area: 1497/2937
Scopus CiteScore
- Year 2017
- CiteScore of the Journal : 1.8
- Area: Gastroenterology Percentile: 36
Journal Citation Indicator (JCI)
- Year 2017
- Journal Citation Indicator (JCI): 0.3
- Best Quartile: Q4
- Area: GASTROENTEROLOGY & HEPATOLOGY Quartile: Q4 Rank in area: 96/124
Abstract
Introduction: Colon capsule endoscopy (CCE) is an alternative approach for the examination of the colon in patients who refuse colonoscopy or after incomplete colonoscopy (IC). We conducted a study to determine the frequency of complete colonoscopy after IC, the diagnostic yield of CCE, the therapeutic impact of lesions found in CCE, the level of colon cleanliness and the safety of the procedure. Methods: We performed a prospective, multicenter study involving ten Spanish hospitals. Consecutive outpatients aged ≥ 18 years with previous IC were invited to participate. The latest version of the CCE device, PillCam™ COLON 2 (CCE-2), was administered to all patients according to the protocol. Results: The study population comprised 96 patients. The most frequent cause of IC was the inability to move past a loop using standard maneuvers (75/96 patients, 78%). Complete visualization of the colon was obtained with CCE-2 in 69 patients (71.9%). Of the 27 patients in whom the CCE-2 did not reach the hemorrhoidal plexus, it passed the colonic segment explored with the previous colonoscopy in 20 cases; therefore, it could be inferred that a combined approach (CCE-2 plus colonoscopy) enabled complete visualization of the colonic mucosa in 92.7% of patients. CCE-2 revealed new lesions in 58 patients (60.4%). Polyps were the most frequent finding (41 patients; 42.7% of the total number of patients). In 43 of the 58 patients (44.8% of the total number of patients), the new lesions observed led to modification of therapy, which included a new colonoscopy for polyp resection or surgery in patients with colonic neoplasm. Conclusions: CCE-2 is a suitable diagnostic procedure that can lead to more frequent diagnosis of significant colonic lesions after IC.